Thalidomide received federal approval Thursday for treatment of bone-marrow cancer, marking the further rehabilitation of a drug originally banned more than 40 years ago after it caused thousands of birth defects. (USATODAY)

April 11, 2005

Celgene Corp. on Monday said initial results from two pivotal-stage trials show that its blood cancer drug Revlimid in combination with chemotherapy significantly delays progression of multiple myeloma in relapsed patients. (Reuters)

Posted by news editor | Filed under: Multiple Myeloma

March 2, 2005

"The Japan branch of the International Myeloma Foundation has repeatedly asked the government to approve thalidomide, saying that thousands of myeloma sufferers who could be saved through its use are dying every year."

Posted by news editor | Filed under: Multiple Myeloma

December 30, 2004

In the lab, multiple myeloma cells are killed by drugs similar to existing anti-diabetes drugs like Avandia or Actos, according to researchers at the University of Rochester School of Medicine and Dentistry, New York. (UPMC Cancer Centers)

Posted by news editor | Filed under: Multiple Myeloma

December 8, 2004

Millennium Pharmaceuticals Inc. on Monday said studies show that its drug Velcade is effective for patients at all stages of the bone marrow cancer multiple myeloma. (UPMC Cancer Centers)

Posted by news editor | Filed under: Multiple Myeloma